Indoco Remedies

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE873D01024
  • NSEID: INDOCO
  • BSEID: 532612
INR
219.55
2.55 (1.18%)
BSENSE

Jul 31, 03:30 PM

BSE+NSE Vol: 1.27 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
467.50
475.61
445.36
484.67
439.67
390.21
410.55
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
467.50
475.61
445.36
484.67
439.67
390.21
410.55
Raw Material Cost
104.58
109.18
97.89
112.99
105.53
85.86
109.91
Purchase of Finished goods
39.89
32.52
32.99
38.82
39.23
30.62
34.93
(Increase) / Decrease In Stocks
13.58
-0.69
-10.46
-6.47
-9.79
-10.51
-30.92
Employee Cost
101.41
109.41
106.03
103.23
107.02
106.32
97.55
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
18.54
17.76
18.31
21.81
21.66
17.39
18.66
Other Expenses
148.48
157.72
169.09
171.24
158.49
161.31
168.39
Total Expenditure (Excl Depreciation)
426.48
425.90
413.85
441.62
422.14
390.99
398.52
Operating Profit (PBDIT) excl Other Income
41.02
49.71
31.51
43.05
17.53
-0.78
12.03
Other Income
2.18
-0.04
0.98
0.76
1.63
2.02
0.85
Operating Profit (PBDIT)
43.20
49.67
32.49
43.81
19.16
1.24
12.88
Interest
28.29
45.92
25.64
24.56
26.12
17.98
16.11
Exceptional Items
97.34
3.74
-6.15
-0.53
0.00
0.00
0.99
Gross Profit (PBDT)
112.25
7.49
0.70
18.72
-6.96
-16.74
-2.24
Depreciation
34.53
32.49
32.01
32.25
29.70
28.78
28.72
Profit Before Tax
77.72
-25.00
-31.31
-13.53
-36.66
-45.52
-30.96
Tax
12.28
-1.32
-1.86
-4.32
-0.31
-4.18
-2.56
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
65.44
-23.68
-29.45
-9.21
-36.35
-41.34
-28.40
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
65.44
-23.68
-29.45
-9.21
-36.35
-41.34
-28.40
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.45
-2.04
0.34
-1.28
-0.56
-0.95
-2.01
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
64.99
-21.64
-29.79
-7.93
-35.79
-40.39
-26.39
Equity Capital
18.46
18.46
18.45
18.45
18.45
18.45
18.44
Face Value
2.0
2.0
2.0
2.0
2.0
2.0
2.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
7.04
-2.34
-3.23
-0.86
-3.88
-4.38
-2.86
Diluted Earnings per share
7.09
-2.56
-3.19
-1.0
-3.94
-4.48
-3.08
Operating Profit Margin (Excl OI)
8.8%
10.9%
7.25%
9.12%
4.07%
-0.2%
2.99%
Gross Profit Margin
24.08%
1.64%
0.16%
3.97%
-1.62%
-4.36%
-0.56%
PAT Margin
14.04%
-5.19%
-6.78%
-1.95%
-8.44%
-10.77%
-7.06%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2026 is -1.71% vs 6.79% in Mar 2026

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2026 is 400.32% vs 27.36% in Mar 2026

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2026 is -17.48% vs 57.76% in Mar 2026

stock-summary

Interest

QoQ Growth in quarter ended Jun 2026 is -38.39% vs 79.10% in Mar 2026

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026

Compare Quarterly Results Of Indoco Remedies With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
467.50
77.24
390.26
505.26%
Other Operating Income
0.00
0.00
0.00
Total Operating income
467.50
77.24
390.26
505.26%
Raw Material Cost
104.58
13.72
90.86
662.24%
Purchase of Finished goods
39.89
5.66
34.23
604.77%
(Increase) / Decrease In Stocks
13.58
-2.30
15.88
690.43%
Employee Cost
101.41
14.88
86.53
581.52%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
18.54
0.00
18.54
Other Expenses
148.48
22.51
125.97
559.62%
Total Expenditure (Excl Depreciation)
426.48
54.47
372.01
682.96%
Operating Profit (PBDIT) excl Other Income
41.02
22.77
18.25
80.15%
Other Income
2.18
1.64
0.54
32.93%
Operating Profit (PBDIT)
43.20
24.41
18.79
76.98%
Interest
28.29
3.08
25.21
818.51%
Exceptional Items
97.34
85.35
11.99
14.05%
Gross Profit (PBDT)
112.25
106.68
5.57
5.22%
Depreciation
34.53
7.04
27.49
390.48%
Profit Before Tax
77.72
101.68
-23.96
-23.56%
Tax
12.28
4.95
7.33
148.08%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
65.44
94.69
-29.25
-30.89%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
65.44
94.69
-29.25
-30.89%
Share in Profit of Associates
0.00
2.04
-2.04
-100.00%
Minority Interest
0.45
-0.25
0.70
280.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
64.99
96.98
-31.99
-32.99%
Equity Capital
18.46
8.51
9.95
116.92%
Face Value
2.00
10.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
7.04
113.96
-106.92
-93.82%
Diluted Earnings per share
7.09
113.71
-106.62
-93.76%
Operating Profit Margin (Excl OI)
8.80%
29.48%
0.00
-20.68%
Gross Profit Margin
24.08%
138.11%
0.00
-114.03%
PAT Margin
14.04%
125.23%
0.00
-111.19%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 467.50 Cr
in Jun 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Jun 2026 is -1.71% vs 6.79% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 6.33% vs 1.90% in Jun 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 64.99 Cr
in Jun 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Jun 2026 is 400.32% vs 27.36% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 281.59% vs -1,466.03% in Jun 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 41.02 Cr
in Jun 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Jun 2026 is -17.48% vs 57.76% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 134.00% vs -63.30% in Jun 2025

Quarterly - Interest
Interest 28.29 Cr
in Jun 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Jun 2026 is -38.39% vs 79.10% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 8.31% vs 82.53% in Jun 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 8.80%
in Jun 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 has improved from Jun 2025